Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-170826
Filing Date
2021-05-24
Accepted
2021-05-24 16:03:00
Documents
2
Group Members
CHARLES I. CLOUGH, JRCLOUGH CAPITAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d181579dsc13ga.htm SC 13G/A 72694
2 EX-99.1 d181579dex991.htm EX-99.1 6280
  Complete submission text file 0001193125-21-170826.txt   80563
Mailing Address 53 STATE STREET 27TH FLOOR BOSTON MA 02109
Business Address 53 STATE STREET 27TH FLOOR BOSTON MA 02109 6172043400
CLOUGH CAPITAL PARTNERS L P (Filed by) CIK: 0001276144 (see all company filings)

EIN.: 043486480 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Subject) CIK: 0001651431 (see all company filings)

EIN.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91617 | Film No.: 21954797
SIC: 2836 Biological Products, (No Diagnostic Substances)